Clinical Trials Browser

Phase 2 × Withdrawn × Hydroxychloroquine × Clear all

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

Phase 2 Withdrawn

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04392128 2020-09-04

HYACINTHE

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms